News
FDA to Ask Sarepta to Halt Elevidys Shipments
Digest more
Three patients with a muscle-wasting disease died from liver failure after taking the therapy, Elevidys, or a similar ...
The death will likely further stoke safety concerns around Sarepta's gene therapies, as well as raise questions around the ...
The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results